Problematic trials are contaminating the evidence ecosystem

Fuchen Liu¹, Chang Xu², Suhail A Doi³, Haitao Chu^{4

5}, Hui Liu^{1

2}

Affiliations

¹ Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital, Second Military Medical University, Naval Medical University, Shanghai, China liuhuigg@hotmail.com.
² Proof of Concept Center, Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital, Second Military Medical University, Naval Medical University, Shanghai, China.
³ Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar.
⁴ Statistical Research and Data Science Center, Pfizer Inc, New York, NY, USA.
⁵ Division of Biostatistics and Health Data Science, University of Minnesota School of Public Health, Minneapolis, MN, USA.

Editorial

Fuchen Liu et al. BMJ. 2025.

. 2025 Apr 24:389:r809.

doi: 10.1136/bmj.r809.

Fuchen Liu¹, Chang Xu², Suhail A Doi³, Haitao Chu^{4

5}, Hui Liu^{1

2}

¹ Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital, Second Military Medical University, Naval Medical University, Shanghai, China liuhuigg@hotmail.com.
² Proof of Concept Center, Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital, Second Military Medical University, Naval Medical University, Shanghai, China.
³ Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar.
⁴ Statistical Research and Data Science Center, Pfizer Inc, New York, NY, USA.
⁵ Division of Biostatistics and Health Data Science, University of Minnesota School of Public Health, Minneapolis, MN, USA.

No abstract available

Conflict of interest statement

Competing interests: None.